Chennagiri R Pandit

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

San Diego, CA (US) (2007 - 2015)
Norfolk, PA (US) (2016)

Company Filing History:

9 out of 2,078

Janssen Pharmaceutica Nv

patents

3 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

Years Active: 2007-2016

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9321729 - Substituted pyridyl amide compounds as modulators of the histamine H3 receptor (2016-04-26),

2. 8940731 - [object Object] (2015-01-27),

3. 8637520 - [object Object] (2014-01-28),

4. 8063206 - Processes for the preparation of cyclopropyl-amide derivatives (2011-11-22),

5. 7947833 - Preparation of quinoxaline compounds (2011-05-24),

6. 7795426 - Processes for the preparation of cyclopropyl-amide derivatives (2010-09-14),

7. 7777031 - Substituted pyridyl amide compounds as modulators of the histamine H3 receptor (2010-08-17),

8. 7728129 - Processes for the preparation of piperazinyl and diazapanyl benzamide derivatives (2010-06-01),

9. 7482364 - Phenylalkynes (2009-01-27),

10. 7446104 - Phenylalkynes (2008-11-04),

11. 7288651 - Preparation of quinoxaline compounds (2007-10-30),

12. 7288540 - Phenylalkynes (2007-10-30),

Innovator Spotlight: Chennagiri R Pandit

Introduction

Chennagiri R Pandit is a prominent inventor based in San Diego, California, known for his significant contributions to the field of pharmacology. With a remarkable portfolio of 12 patents, his work focuses primarily on the modulation of the histamine H3 receptor, which is pivotal in the treatment of various histamine-related diseases.

Latest Patents

Among his latest inventions, Chennagiri R Pandit has developed substituted pyridyl amide compounds as modulators of the histamine H3 receptor. These compounds demonstrate potential therapeutic benefits for treating diseases that are mediated by the histamine H3 receptor. The innovative nature of these compounds showcases Pandit's expertise in addressing critical medical challenges through scientific ingenuity.

Career Highlights

Throughout his career, Chennagiri has worked with respected organizations such as Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation. His experience in these reputable companies has equipped him with the necessary skills to innovate and conduct groundbreaking research in the pharmaceutical industry.

Collaborations

Chennagiri R Pandit has collaborated with notable coworkers, including Neelakandha S Mani and Xiaohu Deng. These professional relationships have contributed to a dynamic exchange of ideas and advancements in their respective projects, fostering an environment of creativity and innovation.

Conclusion

Chennagiri R Pandit continues to be a key figure in the realm of pharmaceutical innovation, with his patents paving the way for new therapeutic approaches. His dedication to advancing medical science through innovative inventions reflects a commitment to improving healthcare outcomes for patients. As he progresses in his career, the impact of his work will undoubtedly leave a lasting legacy in the industry.

This text is generated by artificial intelligence and may not be accurate.